These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30697997)

  • 21. The role of T-type calcium channels in epilepsy and pain.
    Nelson MT; Todorovic SM; Perez-Reyes E
    Curr Pharm Des; 2006; 12(18):2189-97. PubMed ID: 16787249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and characterization of a disubstituted piperazine derivative with T-type channel blocking action and analgesic properties.
    Pudukulatham Z; Zhang FX; Gadotti VM; M'Dahoma S; Swami P; Tamboli Y; Zamponi GW
    Mol Pain; 2016; 12():. PubMed ID: 27053601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-type Calcium Channels in Health and Disease.
    Wang D; Ragnarsson L; Lewis RJ
    Curr Med Chem; 2020; 27(19):3098-3122. PubMed ID: 30277145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies.
    Bezençon O; Heidmann B; Siegrist R; Stamm S; Richard S; Pozzi D; Corminboeuf O; Roch C; Kessler M; Ertel EA; Reymond I; Pfeifer T; de Kanter R; Toeroek-Schafroth M; Moccia LG; Mawet J; Moon R; Rey M; Capeleto B; Fournier E
    J Med Chem; 2017 Dec; 60(23):9769-9789. PubMed ID: 29116786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-type calcium channel as a new therapeutic target for tremor.
    Miwa H; Kondo T
    Cerebellum; 2011 Sep; 10(3):563-9. PubMed ID: 21479969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making the T-type even tinier: corticotropin-releasing factor-mediated inhibition of low-voltage-activated calcium channel activity.
    Varela DL; Hermosilla T; Zamponi GW
    Mol Pharmacol; 2008 Jun; 73(6):1589-91. PubMed ID: 18326584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-type calcium channels in chronic pain: mouse models and specific blockers.
    François A; Laffray S; Pizzoccaro A; Eschalier A; Bourinet E
    Pflugers Arch; 2014 Apr; 466(4):707-17. PubMed ID: 24590509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice.
    Sekiguchi F; Fujita T; Deguchi T; Yamaoka S; Tomochika K; Tsubota M; Ono S; Horaguchi Y; Ichii M; Ichikawa M; Ueno Y; Koike N; Tanino T; Nguyen HD; Okada T; Nishikawa H; Yoshida S; Ohkubo T; Toyooka N; Murata K; Matsuda H; Kawabata A
    Neuropharmacology; 2018 Aug; 138():232-244. PubMed ID: 29913186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-type calcium channel blockers: a patent review (2012-2018).
    Nam G
    Expert Opin Ther Pat; 2018 Dec; 28(12):883-901. PubMed ID: 30372652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of Ca
    Liu QY; Chen W; Cui S; Liao FF; Yi M; Liu FY; Wan Y
    Neurosci Res; 2019 May; 142():30-37. PubMed ID: 29684385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of recombinant low-voltage activated calcium channels.
    Lacinová L
    Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):105-11. PubMed ID: 15078185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-type calcium channels in neuropathic pain.
    Bourinet E; Francois A; Laffray S
    Pain; 2016 Feb; 157 Suppl 1():S15-S22. PubMed ID: 26785151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-channel pharmacology of mibefradil in human native T-type and recombinant Ca(v)3.2 calcium channels.
    Michels G; Matthes J; Handrock R; Kuchinke U; Groner F; Cribbs LL; Pereverzev A; Schneider T; Perez-Reyes E; Herzig S
    Mol Pharmacol; 2002 Mar; 61(3):682-94. PubMed ID: 11854450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of Pseudellone Analogs and Characterization as Novel T-type Calcium Channel Blockers.
    Wang D; Neupane P; Ragnarsson L; Capon RJ; Lewis RJ
    Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30487473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological studies of Cav3.1 T-type calcium channels using automated patch-clamp techniques.
    Choi KH; Song C; Cheong CS; Rhim H
    Gen Physiol Biophys; 2011 Mar; 30(1):100-5. PubMed ID: 21460418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-Type voltage gated calcium channels: a target in breast cancer?
    Bhargava A; Saha S
    Breast Cancer Res Treat; 2019 Jan; 173(1):11-21. PubMed ID: 30242580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cognitive Function and Calcium. Cognitive improvement through T type calcium channel stimulation].
    Fukunaga K
    Clin Calcium; 2015 Feb; 25(2):247-54. PubMed ID: 25634050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in the development of T-type calcium channel blockers for pain intervention.
    Snutch TP; Zamponi GW
    Br J Pharmacol; 2018 Jun; 175(12):2375-2383. PubMed ID: 28608534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of corticotropin-releasing factor receptor 1 selectively inhibits CaV3.2 T-type calcium channels.
    Tao J; Hildebrand ME; Liao P; Liang MC; Tan G; Li S; Snutch TP; Soong TW
    Mol Pharmacol; 2008 Jun; 73(6):1596-609. PubMed ID: 18292205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.